Key takeaways Animal studies show BPC-157 improves gastric motility and protects against gastric damage in rats No human clinical trial has tested BPC-157 for gastroparesis specifically BPC-157 modulates the nitric oxide system and may interact with vagal nerve function, both relevant to gastroparesis Oral administration (250-500 mcg daily) is preferred over injection for GI-targeted effects BPC-157 is unusually stable in stomach acid, making oral delivery viable Patients should work with their gastroenterologist before adding BPC-157 to their gastroparesis management What is gastroparesis and why is it hard to treat
The one significant finding came from a patient questionnaire: self-reported improvement in overall skin quality favoured the GHK-Cu group (P = 0.04).[6] Other frequently quoted claims include increased skin thickness, improved elasticity and reduced wrinkles are largely derived from older cosmetic studies and company-linked research
Ma S, Sun L, Wu W, Wu J, Sun Z, Ren J
However, to achieve safe and meaningful results from peptide therapy, your provider must not only understand the science behind peptides, but also understand your unique biology
Injections ensure your body gets maximum effectiveness compared to oral supplements that may lose potency during digestion
